Xiao Xu

机构：Qingdao University, Zhejiang Chinese Medical University, Communication University of Zhejiang, Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, Jiangsu Province Hospital, Ministry of Public Health, Hangzhou Medical College, Southern Medical University, Zhejiang University, Nanjing Medical University · ORCID：0000-0002-2761-2811

发表论文 552 篇 · 总被引 13969 次 · h-index 60

代表论文

• Pre-existing anti-polyethylene glycol antibodies in pregnant women and newborns (2026 · Journal of Nanobiotechnology · 被引 1)
• Body composition predicts prognosis of patients with hepatocellular carcinoma after liver transplantation: A multicenter study (2025 · Hepatobiliary & pancreatic diseases international · 被引 1)
• Paeoniflorin attenuates hepatic ischemia-reperfusion injury by modulating Tmem176b+ macrophages polarization (2025 · International Immunopharmacology · 被引 1)
• [Efficacy and clinical remission in patients with severe asthma and blood eosinophil counts ≥150 cells/μl treated with benralizumab: a sub-analysis of the Phase 3 MIRACLE study]. (2025 · PubMed · 被引 1)
• PS11.3: In vivo delivery of CRISPR-Cas9 via lipid nanoparticles enhances hepatocyte transplantation by inducing host hepatocyte senescence. (2025 · Transplantation · 被引 1)
• Succinic acid inhibits hepatocyte regenerative signaling via STAT3 SH2-domain engagement (2026 · Molecular Biomedicine)